. Large observational studies using data from RM follow-up databases of device manufacturers, involving >500,000 patients, have evaluated whether RM has a substantial impact on clinical outcomes including survival. These studies consistently show that RM is associated with a survival benefit compared with periodic in-person device follow-up.
Smaller randomized clinical trials have shown less benefit or no significant survival difference.
In this issue of the Journal, 2 studies shed considerable light on this important knowledge gap. 
